Last reviewed · How we verify
Cari Health Inc. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
1 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Neurology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Assistance Publique - Hôpitaux de Paris · 1 shared drug class
- Cedars-Sinai Medical Center · 1 shared drug class
- Depomed · 1 shared drug class
- Mundipharma Pharmaceuticals B.V. · 1 shared drug class
- Norwegian University of Science and Technology · 1 shared drug class
- St. Olavs Hospital · 1 shared drug class
- Talphera, Inc · 1 shared drug class
- The Hospital for Sick Children · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Cari Health Inc.:
- Cari Health Inc. pipeline updates — RSS
- Cari Health Inc. pipeline updates — Atom
- Cari Health Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Cari Health Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/cari-health-inc. Accessed 2026-05-17.